From bench to bedside: navigating the clinical translation of GSK-3β inhibition in lung cancer
Crossref DOI link: https://doi.org/10.1007/s12032-025-03187-1
Published Online: 2025-12-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yu, Tao
Wei, Shan
Text and Data Mining valid from 2025-12-11
Version of Record valid from 2025-12-11
Article History
Received: 28 November 2025
Accepted: 3 December 2025
First Online: 11 December 2025
Declarations
:
: The authors declare no competing interests.
Free to read: This content has been made available to all.